Description (Pan0a 0000 01)
Pantoprazole Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 65219-385
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 65219-385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo Black-fk (Pan0a 0000 02)
Package Label (PRINCIPAL DISPLAY – Pantoprazole Sodium for Injection Vial Label)
This is a description of a vial containing pantoprazole with a concentration of 40 mg per vial. The text mentions reconstitution is needed, and the equivalent sodium content. It also provides storage instructions and indicates that it is for Intravenous Infusion only. Manufacturing information is given, attributing the production to Fresenius Kabi in Lake Zurich, IL.*
Package Label (PRINCIPAL DISPLAY – Pantoprazole Sodium for Injection Tray Label)
This text is a product description for Pantoprazole Sodium for Injection equivalent to 40 mg of Pantoprazole per vial. It is intended for intravenous infusion only as a single-dose vial. Each vial contains 40 mg of Pantoprazole. Reconstitution is needed before administration. Storage instructions include keeping it between 20° to 25°C and protecting vials from light. The product comes with ten vials and a package insert. For inquiries, contact 1-800-551-7176 or visit the website www.fresenius-kabi.com/us.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
